Valeant may sell some assets to reduce debt, according to a report from Bloomberg. Valeant would not comment on the report, which concludes that the company could sell some cosmetics and cancer drug assets.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
